1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GILEAD SCIENCES, INC.
Gilead Sciences, Inc. XNAS: GILD

Gilead Sciences, Inc. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Soval...

Read More
114.09 0.47 (0.41%)
39.42% Gain from 52W Low
12.6M
XNAS Volume
High volume today

XNAS 19 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Affordable Valuation
50.8 / 100
Momentum Score
Technically Neutral
48.6 / 100
Mid-range Performer These stocks may be affordable or expensive, based on their medium quality and mid-range technical score. However, their reasonable financials are successful in gathering some investor interest. View Similar Embed DVM
Analyst Price Target
125
1Yr Price target upside is 10%
25 analysts

13

S

5

W

2

O

1

T

SWOT Analysis

Gilead Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..